Publications by authors named "Lenka Nedbalova"
Article Synopsis
- The study aimed to assess the effectiveness and safety of adalimumab biosimilars FKB327 and GP2017 in treating patients with inflammatory bowel disease (IBD), focusing on Crohn's disease (CD) and ulcerative colitis (UC).
- Of the 50 patients treated, 73.5% with CD achieved remission after 12 weeks, while only 18.8% of UC patients reached remission; overall improvements in disease activity and lab results were noted.
- Seven adverse events were reported, leading to three cases where therapy was discontinued, indicating that while effective, the treatment has potential side effects.
Echinococcus multilocularis causes an aggressive form of hydatidosis whose histomorphological picture is generally not well recognized. We report a case of 39-year-old women presenting with poorly circumscribed nodules in the right hepatic lobe. Owing to the clinical suspicion of focal nodular hyperplasia and hepatocellular adenoma, a core biopsy was performed.
View Article and Find Full Text PDF